BIVISION Trademark

Trademark Overview


On Monday, March 3, 2025, a trademark application was filed for BIVISION with the United States Patent and Trademark Office. The USPTO has given the BIVISION trademark a serial number of 99063519. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 9, 2025. This trademark is owned by Bivision Pharmaceuticals(Nanjing),Inc.. The BIVISION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Diagnostic reagents for medicinal use; Tumor suppressing agents; Diagnostic radiopharmaceutical agent for use in PET imaging; Pharmaceutical preparations for use in urology; Pharmaceutical products for the treatment of cancer; Diagnostic radiopharmaceutical preparations
bivision

General Information


Serial Number99063519
Word MarkBIVISION
Filing DateMonday, March 3, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 9, 2025

Trademark Statements


Description of MarkThe mark consists of the stylized wording of "BIVISION". The mark further consists of a stylized atom as the letter "O" in "BIVISION".
Goods and ServicesPharmaceutical products for the prevention and treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Diagnostic reagents for medicinal use; Tumor suppressing agents; Diagnostic radiopharmaceutical agent for use in PET imaging; Pharmaceutical preparations for use in urology; Pharmaceutical products for the treatment of cancer; Diagnostic radiopharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 3, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBivision Pharmaceuticals(Shanghai),Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 200000
CN

Party NameBivision Pharmaceuticals(Nanjing),Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNanjing 200000
CN

Party NameBivision Pharmaceuticals(Shanghai),Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 200000
CN

Party NameBivision Pharmaceuticals(Nanjing),Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNanjing 200000
CN

Trademark Events


Event DateEvent Description
Monday, March 3, 2025NEW APPLICATION ENTERED
Monday, March 3, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, July 23, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 5, 2025ASSIGNED TO EXAMINER
Tuesday, August 12, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 3, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 9, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 9, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED